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Summary
Objective: This study represents an early attempt to determine the diversity of Mycobacterium
tuberculosis in Egypt, particularly of drug-resistant strains.
Methods: We characterized 45 Mycobacterium tuberculosis complex isolates from sputum
samples of Egyptian patients with pulmonary tuberculosis, in order to establish a database of
strain types and antimicrobial susceptibility patterns.
Results: One Mycobacterium bovis and 44 Mycobacterium tuberculosis (MTB) isolates were
identified by PCR-restriction fragment length polymorphism (RFLP) analysis of the oxyR gene.
Twenty-five (56.8%) of the 44 MTB isolates were susceptible in vitro to all anti-tuberculosis drugs
tested; five (11.4%) were mono-resistant to isoniazid or streptomycin (four were resistant to
streptomycin and only one was resistant to isoniazid) and 14 (31.8%) were resistant to more than
one drug (multidrug-resistant, MDR). Among the 44 MTB isolates tested by RFLP analysis in this
study, 40 different RFLP patterns were obtained. The number of IS6110 copies ranged from 5 to
16. Studying the IS6110 RFLP patterns indicated that the 44 isolates did not cluster together but
were generally scattered. None of the 14 MDR isolates were clustered. Twenty-two different
spoligotypes were identified among the 44 MTB isolates, of which 13 were unique. The remaining
31 isolates were grouped into nine clusters of strains sharing identical spoligotypes.
Conclusions: We have demonstrated evidence of diversity among the drug-susceptible and
resistant MTB strains. Continued surveillance for strains of MTB involved in pulmonary tubercu-
losis in Egypt, and especially for drug-resistant strains, is warranted.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +20 102416336.
E-mail address: saidabbadi@hotmail.com (S. Abbadi).
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Epidemiologic studies of tuberculosis can be greatly facili-
tated by the use of strain-specific markers. TransposablePublished by Elsevier Ltd. All rights reserved.
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have been shown to be of great potential for use in strain
identification. Transposable elements include insertion
sequences (IS), which are small mobile genetic elements
widely distributed in most bacterial genomes, carrying only
the genetic information related to their transposition and
regulation, and transposons, which are mobile genetic ele-
ments that also carry genes that encode phenotypic markers
(e.g., antibiotic resistance).
Key factors in the control of tuberculosis are rapid detec-
tion, adequate therapy, and contact tracing to halt further
transmission. Recent developments in DNA technology and
molecular biology have led to methods for the rapid detec-
tion of mycobacterial DNA by nucleic acid amplification.1
These methods include: DNA fingerprinting, based on the
polymorphism of the insertion sequence IS6110 among MTB
complex strains,2 pTBN12 fingerprinting based on the poly-
morphic GC-rich sequence (PGRS),3 spoligotyping based on
the analysis of polymorphisms in the DR (direct repeat)
locus,1 and variable-number tandem repeats (VNTR) typing.4
Among these methods, IS6110 fingerprinting is the recom-
mended standard primary genotyping method,5 and this
method has been used routinely worldwide.6 Clinical isolates
of MTB obtained from patients infected by the same strain of
bacillus usually exhibit identical or very similar (with one
band variation) IS6110 fingerprint patterns, and the patients
are more often found to be epidemiologically linked.7
Although IS6110 fingerprinting is the gold standard method
of typing, its major limitation is that genotype clustering is
not synonymous with epidemiologically defined clustering
(patient—patient link); it also has a low discriminating power
for isolates with fewer than six copies of IS6110. In the case
where the IS6110 is not definitive, mycobacterial inter-
spersed repetitive unit—variable number tandem repeat
analysis (MIRU/VNTR) or spoligotyping is usually needed as
a secondary method of typing.4 These secondary typing
methods have the advantage of being less time consuming
as they are PCR-based.8 Disadvantages of these methods are
that they are labor intensive and that the hybridization
patterns generated are often too complex to be computer-
ized for standardization and analysis. Also, their discrimina-
tory power is lower than that of IS6110 typing in high copy
number isolates.
The increased application of DNA fingerprinting has
advanced the understanding of the dynamics of tuberculosis
epidemiology.9 The incidence of tuberculosis in a community
is a function of both the rate at which latent M. tuberculosis
infections are reactivated and the number of case contacts
who develop primary tuberculosis.10 Molecular typing has
provided an insight into the impact of reinfection on recur-
rent tuberculosis in comparison to reactivation.11 Molecular
typing of MTB isolates has also proven to be a useful tool in
confirming laboratory cross-contamination12 and investigat-
ing nosocomial and institutional transmission.13
Directly observed therapy (DOT) has been shown to
decrease the incidence of active tuberculosis in the commu-
nity and to reduce rates of drug-resistant tuberculosis.10 DOT
decreases tuberculosis transmission by providing greater
certainty that patients with active tuberculosis will become
non-infectious soon after initiation of therapy and by redu-
cing the rate of relapse. The rapid improvement of commu-
nity tuberculosis rates following the implementation of DOTsuggests that a significant proportion of disease cases in these
populations is as a result of recently transmitted infection
rather than reactivation of long-standing latent tuberculosis.
Such analyses also predict that the effective implementation
of DOT in a community will greatly reduce recently trans-
mitted tuberculosis, but will not have a significant short-term
impact on the rates of tuberculosis stemming from reactiva-
tion of old disease.
This study represents an early attempt to determine the
diversity of M. tuberculosis in Egypt, particularly the drug-
resistant strains, consistent with efforts made in low-inci-
dence countries. In this study we characterize M. tubercu-
losis complex (MTC) isolates from the sputum of patients
infected with MTB from Egypt, in order to establish a data-
base of strain types and antimicrobial susceptibility patterns.
We demonstrate evidence of diversity among multidrug-
resistant (MDR) MTB and drug-susceptible MTB strains.
Materials and methods
Bacterial isolates
Forty-five clinical isolates (one isolate per patient) were
included in this study. All specimens were isolated from
sputum samples from patients with pulmonary tuberculosis
in the Suez Canal region of Egypt.
Isolation and preliminary identification of MTB
strains
After concentration/decontamination of sputum samples by
the NALC method (N-acetyl-L-cysteine), sputum cultures
were done on Lowenstein—Jensen (LJ) medium. Isolation
and identification of MTC were performed as previously
described.14
Antimicrobial susceptibility testing
Isolates of MTC were tested by the modified method of
proportion as described by Kent and Kubica14 using Middleb-
rook 7H10 agar plates containing rifampin (RIF), isoniazid
(INH), streptomycin (STR), ethambutol (EMB), and pyrazina-
mide (PZA). The following critical concentrations were used:
RIF 1.0 mg/ml, INH 0.2, 1.0, and 5.0 mg/ml, STR 2.0 and
10.0 mg/ml, EMB 5.0 mg/ml, and PZA 25.0 mg/ml.
Molecular identification of MTB isolates
DNA of suspected MTB isolates was extracted by the mini-
glass bead agitation procedure as previously described.15 PCR
amplification of IS6110 (MTB complex-specific) and IS1245
(Mycobacterium avium-specific)16 was performed in a multi-
plex PCR assay.
The multiplex PCR assay was performed on the purified
DNA as follows: In a final volume of 25 ml, 1 ml of DNA
template, 0.6 ml (5 mM) of each of the four primers, and
12.5 ml HotStar Taq Master Mix (Taq DNA polymerase, 10 Taq
buffer, 3 mM MgCl2, and 400 mM dNTPs; Qiagen, CA, USA)
were added to 9.1 ml distilled water. The primers used to
amplify a 123-bp fragment of IS6110 were: KDE1 (50-CCT GCG
AGC GTA GGC GTC GG) and KDE2 (50-CTC GTC CAG CGC CGC
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IS1245 were: MA1 (50-CTT GCT GGA GGT GCT CGA CG) and
MA2 (50-GGA GGT GCC GTG CAG GTA GG). MTB strain H37Rv
and M. avium ATCC 871031 were used as PCR controls.
Thermocycling was done in a Gene-Amp PCR system 9700
Thermocycler (Perkin-Elmer Inc., CA, USA). PCR conditions
were as follows: Initial denaturation at 96 8C for 15 min, then
35 cycles of denaturation at 96 8C for 30 s, annealing at 64 8C
for 30 s, and extension at 72 8C for 30 s. A final extension at
72 8C for 7 min was done at the end of these cycles. PCR
amplicons were electrophoresed through 2% agarose gel
supplemented with 50 mg ethidium bromide, at 100 V for
1 h. DNA bands were visualized by UV transilluminator and
compared to control strains.
PCR-restriction fragment length polymorphism
(RFLP) analysis of the oxyR gene
Isolates were further characterized by PCR-RFLP analysis of
the oxyR gene to differentiate between Mycobacterium bovis
and M. tuberculosis within the MTB complex. A 548-bp seg-
ment of theoxyR genewas amplifiedas previously described,17
using the following oligonucleotide primers: forward primer,
50-GGT GATATATCA CAC CATA-30; reverse primer, 50 -CTATGC
GATCAGGCGTACTTG-30. The following cyclic conditionswere
used for amplification of the oxyR gene: Denaturation at 96 8C
for 5 min, 35 cycles of 30 s at 96 8C, 30 s at 57 8C, and 45 s at
72 8C, and a final extension for 6 min at 72 8C. DNA gel elec-
trophoresiswas done to test the amplification using 2%agarose
gel under 100 V for 1 h. The PCR product (10 ml) was digested
with 4 U of AluI (New England Biolabs, Beverly, MA, USA). The
reaction mix included 12 ml water, 2.5 ml enzyme buffer, and
10 ml PCR product. A 100-bp marker was used as a ladder.
Novex precast acrylamide gel (4—20%) was used for the gel
electrophoresis for 3 h, at 100 V, using Tris-borate-EDTA (TBE)
buffer cooled to 6 8C.
Strain typing (IS6110 RFLP)
Isolates of MTB were typed by the standard IS6110-RFLP
method as described by van Embden et al.5 Briefly, a 2—3-
week-old subculture isolate in 7H9 broth was incubated over-
night with cycloserine (1 mg/ml) at 37 8C. The sedimented
cells were harvested into a 1.5 ml microcentrifuge tube and
incubated for 20 min at 80 8C. Chromosomal DNAwas isolated
by disruption of the cells with siliconized glass beads as pre-
viously described.15 Approximately 0.75—1.25 mg of genomic
DNA was digested for 2 h with 10 U of pvuII (BRL Life Technol-
ogies Inc., Gaithersburg, MD, USA) and electrophoresed on
1.0% agarose gel overnight. The restriction fragments were
transferred by vacuum blotting to a Hybond-N+ nylon mem-
brane (Amersham Corp., Arlington Heights, IL, USA). Hybridi-
zation was carried out under stringent conditions with 247-bp
IS6110 PCR fragment, using the Amersham ECL direct labeling
and detection kit. Banding patterns on resulting autoradio-
graphs were scanned and analyzed using molecular analysis
software (Bio Image, Ann Arbor, MI, USA).15
Spoligotyping
Spoligotyping was performed as previously described by
Kamerbeeketal.18 Thedirect repeat (DR) regionwas amplifiedby PCR using primers derived from the DR sequence. The
primers used were DRa (GGTTTTGGGTCTGACGAC) and DRb
(CCGAGAGGGGACGGAAAC). Fifty microliters of the following
reactionmixturewere used for the PCR: 10 ng of DNA, 20 pmol
each of primers DRa and DRb, each deoxynucleoside tripho-
sphate at 200 mM, PCR buffer, and 0.5 U of Taq polymerase.
The mixture was heated for 3 min at 96 8C and subjected to 20
cycles of 1 min at 96 8C, 1 min at 55 8C, and 30 s at 72 8C. The
amplified DNA was hybridized to a set of 43 immobilized
oligonucleotides, each corresponding to one of the unique
spacer DNA sequences within the DR locus. The sequences of
the oligonucleotides used are given in Table 1. These oligonu-
cleotideswerecovalently bound toahybridizationmembrane.
Themembrane (Biodyne C)was obtained fromPall Biosupport,
Portsmouth, UK, and was activated as previously described.18
For hybridization, 20 ml of the amplified PCR product were
diluted in 150 ml of 2 saline-sodium phosphate-EDTA (SSPE)
supplemented with 0.1% sodium dodecyl sulfate, and heat
denatured. The diluted samples (130 ml) were pipetted into
the parallel channels in such a way that the channels of the
miniblotter apparatus were perpendicular to the rows of oli-
gonucleotides deposited previously. Hybridization was done
for 60 min at 60 8C. After hybridization, the membrane was
washedaspreviouslydescribed.18DetectionofhybridizingDNA
wasdoneusing a chemiluminescentECL (Amersham)detection
kit. The 43-digit binary result was converted into a 15-digit
octal designation as previously described.19
Results
MTC was cultured from sputum samples of 45 patients with a
presumptive diagnosis of pulmonary tuberculosis from the
Suez Canal region. All isolates contained IS6110 based upon
PCR amplification of a 123-bp region of the insertion ele-
ment. Among the 45 human isolates, one was determined to
be M. bovis and 44 were M. tuberculosis based on amplifica-
tion of a 270-bp region of oxyR.
Antimicrobial susceptibility testing
Twenty-five (56.8%) of the 44 MTB isolates were susceptible in
vitro to all anti-tuberculosis drugs tested; five (11.4%) were
mono-resistant to INH or STR (four were resistant to STR and
only one was resistant to INH) and 14 (31.8%) were resistant
to more than one drug (MDR). The 14 MDR strains included six
strains resistant to four drugs, three resistant to INH and RIF,
three resistant to INH and STR, one resistant to INH, RIF, and
EMB, and one resistant to INH, RIF, and STR (Table 2).
Strain types (IS6110 RFLP)
Among the 44 MTB isolates tested for RFLP analysis in this
study, 40 different RFLP patterns were obtained (Table 3).
The number of IS6110 copies ranged from 5 to 16 (Figure 1).
Studying the IS6110 RFLP patterns indicated that the 44
isolates did not cluster together but were generally scat-
tered. Eight isolates were clustered together in four pat-
terns, two isolates each. These two pairs of isolates hadmore
than 90% similarity but still had one difference in IS6110-
hybridization band within each pair. All eight isolates were
susceptible to all anti-tuberculosis drugs tested in this study,
Table 1 Sequences of the oligonucleotides used in the study
Space No. Oligonucleotide sequence Space No. Oligonucleotide sequence
1 ATAGAGGGTCGCCGGTTCTGGATCA 23 AGCATCGCTGATGCGTCCAGCTCG
2 CCTCATAATTGGGCGACAGCTTTTG 24 CCGCCTGCTGGGTGAGACGTGCTCG
3 CCGTGCTTCCAGTGATCGCCTTCTA 25 GATCAGCGACCACCGCACCCTGTCA
4 ACGTCATACGCCGACCAATCATCAG 26 CTTCAGCACCACCATCATCCGGCGC
5 TTTTCTGACCACTTGTGCGGGATTA 27 GGATTCGTGATCTCTTCCCGCGGAT
6 CGTCGTCATTTCCGGCTTCAATTTC 28 TGCCCCGGCGTTTAGCGATCACAAC
7 GAGGAGAGCGAGTACTCGGGGCTGC 29 AAATACAGCTCCACGACACGACCA
8 CGTGAAACCGCCCCCAGCCTCGCCG 30 GGTTGCCCCGCGCCCTTTTCCAGCC
9 ACTCGGAATCCCATGTGCTGACAGC 31 TCAGACAGGTTCGCGTCGATCAAGT
10 TCGACACCCGCTCTAGTTGACTTCC 32 GACCAAATAGGTATCGGCGTGTTCA
11 GTGAGCAACGGCGGCGGCAACCTGG 33 GACATGACGGCGGTGCCGCACTTGA
12 ATATCTGCTGCCCGCCCGGGGAGAT 34 AAGTCACCTCGCCCACACCGTCGAA
13 GACCATCATTGCCATTCCCTCTCCC 35 TCCGTACGCTCGAAACGCTTCCAAC
14 GGTGTGATGCGGATGGTCGGCTCGG 36 CGAAATCCAGCACCACATCCGCAGC
15 CTTGAATAACGCGCAGTGAATTTCG 37 CGCGAACTCGTCCACAGTCCCCCTT
16 CGAGTTCCCGTCAGCGTCGTAAATC 38 CGTGGATGGCGGATGCGTTGTGCGC
17 GCGCCGGCCCGCGCGGATGACTCCG 39 GACGATGGCCAGTAAATCGGCGTGG
18 CATGGACCCGGGCGAGCTGCAGATG 40 CGCCATCTGTGCCTCATACAGGTCC
19 TAACTGGCTTGGCGCTGATCCTGGT 41 GGAGCTTTCCGGCTTCTATCAGGTA
20 TTGACCTCGCCAGGAGAGAAGATCA 42 ATGGTGGGACATGGACGAGCGCGAC
21 TCGATGTCGATGTCCCAATCGTCGA 43 CGCAGAATCGCACCGGGTGCGGGAG
22 ACCGCAGACGGCACGATTGAGACAA
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whose isolates had clustered in four clusters. All MDR-TB
isolates showed unique RFLP patterns. The 40 RFLP patterns
were compared with those in a database containing more
than 6000 distinct patterns at the Centers for Disease Control
and Prevention, and no similarity was found with our isolates.
Interestingly, when these 40 patterns were compared with 53
patterns previously isolated from the cerebrospinal fluid of
patients with meningitis in Egypt,20 only one pattern (pattern
6) was found to be very similar (this isolate was found to be
MDR). None of the RFLP patterns found among the 25 isolates
from pulmonary tuberculosis at Assiut University Hospital,
Egypt, matched those found in our isolates.21Table 2 RFLP types according to the antimicrobial suscept-
ibility patterns of the 44 tested Mycobacterium tuberculosis
isolates from sputum samples of pulmonary tuberculosis
patients in Egypt
Resistance pattern No. of isolates RFLP patterns
INH 1 32
STR 4 22, 30, 5, 16
RIF + INH 3 6, 15, 38
INH + STR 3 2, 5, 17
INH + RIF + STR 1 3
INH + RIF + EMB 1 39
INH + RIF + STR
+ EMB
6 7, 9, 10, 20,
21, 40
None 25 Multiple *
Total 44
RFLP, restriction fragment length polymorphism; INH, isoniazid;
STR, streptomycin; RIF, rifampin; EMB, ethambutol.
* 21 RFLP patterns.Spoligotyping
Twenty-two different spoligotypes were identified among the
44 MTB isolates (Figure 2), of which 13 were unique (Table 3).
The remaining 31 isolates were grouped into nine clusters of
strains sharing identical spoligotypes. The most common
patterns, A and H, were found among 12 and four isolates,
respectively. The spoligotype pattern G was observed in
three isolates, while spoligotypes C, E, I, K, M, and S were
observed for two isolates. RFLP clusters were not further
subdivided by spoligotyping. Isolates from three of the RFLP
clusters (RFLP patterns 21, 26, and 28) that contained two
isolates were present in spoligotype pattern A (Table 3). A
different spoligotype was found for the remaining RFLP
cluster that contained two isolates. Nine RFLP patterns were
found among isolates with the most common spoligotype
(pattern A), and four RFLP patterns were found among the
four isolates with spoligotype pattern H. Spoligotype pat-
terns A and H were also found to be the most common
patterns among 67 isolates from meningitis patients at six
fever hospitals in Egypt.20 Spoligotype patterns A, F, I, and J
were also found in a collection of 25 isolates from pulmonary
tuberculosis patients at Assiut University Hospital, Egypt.21
Five spoligotypes (patterns A, F, H, I, and J) were present in
the Rijksinstituut voor Volksgesondheit en Milieuhygiene
international database (National Institute of Public Health
and Environment, Bilthoven, the Netherlands).6 These pat-
terns were reported from one to 16 countries (but not from
Egypt), and spoligotype patterns A and H were reported from
the most countries (16 and 13 countries, respectively). Spo-
ligotype patterns H and J were reported in the Rijksinstituut
voor Volksgesondheit en Milieuhygiene database from three
African countries, and patterns A and H were also reported
from Iran.6
Table 3 Spoligotypes of 44 Mycobacterium tuberculosis isolates from sputum of patients with pulmonary tuberculosis in Egypt
Spoligotype Number of isolates Spoligotypea RFLP type(s)
Ab 12 777777777760771 1, 21c, 25, 26c,
27, 28c, 38, 39, 40
B 1 777777367720771 2
C 2 777777377760771 9, 3
D 1 777777777740171 4
E 2 477677577760771 6, 19
Fb 1 377777607760771 5
G 3 437777777760771 20, 7, 10
Hb 4 777777607760771 8, 12, 32, 33
Ib 2 703777740003171 31, 11
Jb 1 776377777760771 13
K 2 777777607760751 14
L 1 037637767760771 15
M 2 770000777760771 16, 17
N 1 703777740003771 22
O 1 703777600003171 29
P 1 776367777760771 30
Q 1 777777601760771 24
R 1 777777347760471 35
S 2 777777777620771 23, 34
T 1 677777777413731 37
U 1 776377740000031 36
V 1 777737607760771 18
Total 44 40
RFLP, restriction fragment length polymorphism.
a 15-digit octal code.
b Types were found among Egyptian isolates isolated in previous studies.
c Each RFLP pattern contained two isolates.
Figure 1 IS6110 RFLP patterns of 18 Mycobacterium tubercu-
losis isolates. (S, size standard.)
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different RFLP patterns (Table 2); all of the three isolates
were resistant to four anti-tuberculosis drugs (MDR).
Discussion
Patients in this study were all from Suez Canal chest hospi-
tals, which serve patients from all regions of the Suez Canal
area. This makes our data a likely representation of the
genetic makeup of strains throughout this region of Egypt.
All of the 45 isolates in our study were obtained from cases
under DOT. This and other treatment practices that could
influence antimicrobial resistance do not differ from other
regions in Egypt.
Among the 45MTC isolates from sputum samples obtained
from the Suez Canal chest hospitals in Egypt, 44 were
identified as MTB and one as M. bovis by PCR-RFLP analysis
of oxyR. This finding suggests thatM. bovis plays aminor role
compared to MTB in the etiology of pulmonary tuberculosis
in Egypt. We found 40 IS6110 RFLP patterns among the 44
MTB isolates tested. None of these patterns may be con-
sidered low-copy number (<5 bands). Nonetheless, eight
isolates (18.2%) were in four RFLP clusters, two isolates
each. In contrast to findings expected in the common diag-
nosis of pulmonary tuberculosis, no transmission links among
clustered isolates obtained were found. One possible expla-
nation for the absence of transmission links is that clustered
isolates may have resulted from remote transmission of
Figure 2 Spoligotypes from amplified mycobacterial DNA of purified Mycobacterium tuberculosis DNA from strain H37Rv (lane 1),
purified Mycobacterium bovis from strain BCG (lane 2), and Mycobacterium tuberculosis DNA strains cultured from clinical specimens
(lanes 4—40).
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Another factor that might support the idea of remote trans-
mission is the implementation of DOT in this region; it is
predicted that the effective implementation of DOT in a
community will greatly reduce recently transmitted tuber-
culosis but will not have a significant short term impact on
the rates of tuberculosis stemming from reactivation of old
disease.10 This low level of strain relatedness is consistent
with rates reported by Cooksey et al.,20 who examined 67
MTB isolates frommeningitis patients in Egypt. Among the 67
M. tuberculosis isolates, 53 unique strain types (with three
to 16 copies of IS6110) were found by RFLP analysis. Nine
clusters (eight with two isolates each and one with six
isolates) were also found. Also, Abbadi et al.21 studied 25
MTB isolates from Assiut, Egypt. They found 21 different
RFLP patterns. However, our results contrast rather sharply
with the high degree of clustering previously reported in two
other regions of Africa. In Ethiopia and Tunisia, 52% and 62%
ofM. tuberculosis isolates studied, respectively, were found
to belong to three or four genotypic families.22 A high
prevalence of clustering was also found in population-based
studies from Botswana (42%)23 and South Africa (45%).24
Recent reports have described a cluster of extensively
drug-resistant tuberculosis (XDR-TB) cases in the KwaZulu
Natal province of South Africa.25 In KwaZulu Natal, two
distinct strains of XDR-TB were described among the 53
cases, both of which are known to be endemic to the area.This indicates that multiple instances of de novo XDR devel-
opment and transmission of resistant strains between indi-
viduals were occurring simultaneously. The explanation of
this difference in genetic distance found in the KwaZulu
Natal study and our study is thatmost of their cases (44 out of
53) were HIV-positive and severely immunocompromised,
with a median CD4 count of 63 (range 9—283), while in our
study, all cases were HIV-negative, and also our resistant
strains were MDR not XDR.
Strain identification by spoligotyping was less definitive
than RFLP typing, since 31 of 44 isolates (70%) were in
spoligotype clusters: three clusters with 12 isolates, four,
and three isolates, respectively, and six clusters each with
two isolates. However, these results agree with the results of
Cooksey et al.,20 who found that 36 spoligotypes were
observed among 67 MTB isolates from Egyptian meningitis
patients. Five spoligotypes (A, F, H, I, and J) have already
been reported in Egyptian isolates,20 two of these spoligo-
types represent the main two clusters found: type A (12
isolates) and type H (four isolates). Five out of the 14
(35.7%) MDR-TB isolates have been reported before in
Egypt.20 Four of these five isolates (80%) were clustered in
type A spoligotype, which was reported previously as the
most common type in Egypt.20 This result may indicate that
this is a virulent strain.
The spoligotyping procedure, however, may be more
easily implemented than RFLP in laboratories where no M.
242 S. Abbadi et al.tuberculosis typing capabilities are currently present. How-
ever, spoligotyping could produce clusters most similar to
RFLP types when used in conjunction with MIRU-VNTR.4
No clustering of resistant strains by RFLP analysis was
observed among the isolates. Overall antimicrobial suscept-
ibilitieswere similar to those reported among 857MTC isolates
at Abbasia Hospital from 1976 to 1996.26 Less single drug
resistance to RIF and INH was found among our isolates,
comparedto150 isolates tested in theprevious study.Fourteen
outof44 (31.8%)ofour isolateswere resistant tomorethanone
drug, but none was related by RFLP analysis. The overall
prevalence of resistance among these isolates was lower than
that previously reported in 1996 by the National Tuberculosis
Program (NTP) for pulmonary isolates.27 Among 250 isolates
tested in the NTP study, 55.2% were resistant, compared to
43.2% of our isolates. However, resistance to INH was more
common among our isolates (15/44 (34.2%)) than among the
NTP isolates (6.4%). Continued surveillance for strains of M.
tuberculosis involved in pulmonary tuberculosis in Egypt, and
especially for drug-resistant strains, is warranted.
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